Gemcitabine/nabpaclitaxel in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: a retrospective analysis on the efficacy and safety profile

被引：0
|
作者：
Ventriglia, J. [1 ]
Laterza, M. M. [1 ]
Savastano, B. [1 ]
Petrillo, A. [1 ]
Tirino, G. [1 ]
Pompella, L. [1 ]
Pappalardo, A. [1 ]
Orditura, M. [1 ]
Ciardiello, F. [1 ]
De Vita, F. [1 ]
机构：
[1] Univ Campania L Vanvitelli, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
D26
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of gemcitabine/nabpaclitaxel in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: a retrospective analysis
    Ventriglia, J.
    Laterza, M. M.
    Savastano, B.
    Petrillo, A.
    Tirino, G.
    Pompella, L.
    Pappalardo, A.
    Orditura, M.
    Ciardiello, F.
    De Vita, F.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [2] Gemcitabine/nabpaclitaxel efficacy in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma
    Michalaki, V.
    Poydorou, A.
    Frangulidis, G.
    Vezakis, A.
    Karvouni, E.
    Papadimitriou, C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 44 - 44
  • [3] Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis
    Baldini, C.
    Escande, A.
    Bouche, O.
    El Hajbi, F.
    Volet, J.
    Bourgeois, V.
    Vantroys, T. Renaut
    Ploquin, A.
    Desauw, C.
    Hebbar, M.
    [J]. PANCREATOLOGY, 2017, 17 (01) : 146 - 149
  • [4] Retrospective analysis of prognostic and predictive markers in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with gemcitabine/nabpaclitaxel: Influence of the presence of stent
    Fernandez Montes, Ana
    Gonzalez Villarroel, Paula
    Valladares Ayerbes, Manuel
    De la Camara Gomez, Juan Cruz
    Quintero, Guillermo
    Vazquez Tunas, Lidia
    Salgado Fernandez, Mercedes
    Jorge Fernandez, Monica
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [5] Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study
    Inal, A.
    Isikdogan, A.
    Kos, T.
    Algin, E.
    Gumus, M.
    Dikilitas, M.
    Elkiran, E. T.
    Helvaci, K.
    Geredeli, C.
    Dane, F.
    Balakan, O.
    Durnali, A. Gok
    Harputluoglu, H.
    Goksel, G.
    Ozdemir, N.
    Buyukberber, S.
    Yildiz, R.
    Kaplan, M. A.
    Ozkan, M.
    Uncu, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Evofosfamide combined with gemcitabine/nabpaclitaxel in patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma (PAC): Results of a phase I trial
    Borad, Mitesh J.
    Kwak, Eunice Lee
    Wang-Gillam, Andrea
    Ibrahim, Ayman
    Aldridge, Julie
    Olszanski, Anthony J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Effectiveness and safety of nab-paclitaxel/gemcitabine in locally advanced or metastatic pancreatic adenocarcinoma
    Nebot-Villacampa, Maria-Jose
    Zafra-Morales, Ricardo
    Alfaro-Olea, Ascension
    Marin-Gorricho, Raquel
    Casajus-Navasal, Andrea
    Uriarte-Pinto, Moises
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (03) : 603 - 611
  • [8] Neoadjuvant FOLFIRINOX and/or gemcitabine/nabpaclitaxel for advanced pancreatic adenocarcinoma.
    Turner, Keli
    Narayanan, Sumana
    Attwood, Kristopher
    Hochwald, Steven N.
    Iyer, Renuka V.
    Kukar, Moshim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [9] Outcomes of anlotinib plus nabpaclitaxel/gemcitabine as first-line treatment for patients with advanced pancreatic adenocarcinoma: A retrospective analysis in China
    Wu, Hongyang
    Huang, Nana
    Zhao, Chenchen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [10] Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: A retrospective analysis
    Papadoniou, Nikitas
    Kosmas, Christos
    Gennatas, Kostadinos
    Polyzos, Aris
    MouratidoU', Despina
    Skopelitis, Elias
    Tzivras, Michalis
    Sougioultzis, Stavros
    Papastratis, George
    Karatzas, Gavrilos
    Papalambros, Efstathios
    Tsavaris, Nikolas
    [J]. ANTICANCER RESEARCH, 2008, 28 (1B) : 543 - 549
12345